Cryoport, Nippon Express Establish Supply Chain Services Collaboration
The companies will partner up to design and implement solutions that support each other's business efforts.
Cryoport Inc.—a temperature-controlled supply chain solution provider for the life sciences industry that recently grew its network with the acquisition1 of Bluebird Express, LLC, a provider of time-sensitive domestic and international transportation services—and Nippon Express Holdings, Inc., global logistics company, are forming a strategic partnership2 that is expected to provide temperature-controlled supply chain services for the life sciences industry on a global basis.
The parties will partner up in an effort to design and implement supply chain solutions that support each other's business efforts. This relationship combines Nippon Express' logistics experience, with Cryoport Systems' fully integrated system, processes, and equipment including its shipping packages, data solutions, biostorage and bioservices, and a know-how of providing end-to-end cell and gene therapy support services, from upstream biomaterial collection to final delivery for dosing.
"This partnership builds on our growing presence globally and bolsters our ability to service customers by benefiting from Nippon Express' industry-leading global network,” says Jerrell Shelton, CEO of Cryoport. “As an organization, Cryoport is committed to enhancing its logistics solutions and adding new capabilities to support the life sciences. Today's collaboration is the latest in a series of strategic partnerships to build greater value for our clients as we fulfill this mission."
References
1. Cryoport Acquires Bluebird Express. Pharmaceutical Commerce. November 20, 2023. Accessed November 29, 2023. https://www.pharmaceuticalcommerce.com/view/cryoport-acquires-bluebird-express
2. Cryoport and Nippon Express Holdings Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services. PR Newswire. November 27, 2023. Accessed November 29, 2023. https://www.prnewswire.com/news-releases/cryoport-and-nippon-express-holdings-form-global-strategic-partnership-for-temperature-controlled-supply-chain-services-301995552.html
Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In
October 30th 2024In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications.
